An illustration of messenger ribonucleic acid (mRNA)
Kateryna Kon/Science Photo Library/Getty Images
Sixteen people have benefited from an experimental mRNA therapy that replaces a faulty enzyme behind a rare genetic disorder, the biotech company Moderna announced on May 19. This is great news for people with this condition, but its significance goes further: if this type of mRNA therapy proves to be safe and effective, it could help treat a wide range of conditions and could even revolutionize the medicine.
The people in the trial, ages 1 and older, have a condition called propionic acid…